VitaPCR™ SARS-CoV-2 RNA detection Assay can correctly detect Omicron sub-lineages BA.4 and BA.5
In response to the new Omicron variant (also known as B […]
In response to the new Omicron variant (also known as B […]
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.
